Alopecia

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata

Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients

A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors

Dupilumab in the Treatment of Pediatric Alopecia Areata

Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia

Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome

Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia

PRP Combined With Botulinum Toxin Type A Injection for the Treatment of Androgenetic Alopecia: A Study

A Study of LAD603 in Adults With Alopecia Areata

A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia

Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia

A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)

A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes

Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata

Scalp Cooling in MBC

Safety and Efficacy of VDPHL01 in Males and Females With AGA

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata

Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata

Evaluation of Exosomes Injection in Treatment of Male Androgenetic Alopecia: Clinical and Immunohistochemical Study

Regeneron AA Multicenter (Dupilumab)

A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.

Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients

Autologous Adipose Cells Therapy

Various Procedural Treatment Options for Androgenetic Alopecia

Evaluating the Effectiveness and Tolerance of Baricitinib in the Treatment of Acute Alopecia Areata With Active Hair Shedding: A Prospective Open-Label Study

The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia.

Safety and Efficacy of Oral NXC-736 in Adult Participants with Moderate and Severe Alopecia Areata

Evaluation of Latanoprost Combined With Fractional Erbium- YAG Laser

Use of Botulinum Toxin in the Treatment of Androgenic Alopecia

A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata

Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants

Effectiveness of Apheresis Platelet-Rich Plasma Injection for Androgenic Alopecia

Tofacitinib for Immune Skin Conditions in Down Syndrome

Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA

Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia

PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA

A Study to Assess the Efficacy and Safety of HMI-115 in Male Subjects With Androgenetic Alopecia

A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata

Activated PRP for Treatment of Androgenetic Alopecia

Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata

Ritlecitinib for Cicatricial Alopecia

A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia

LEO 124249 Ointment in the Treatment of Alopecia Areata

Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata.

To Compare the Efficacy of Weekly Azathioprine Pulse Versus Betamethasone Oral Mini-Pulse in the Treatment of Moderate to Severe Alopecia Areata

Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata

To Evaluate the Efficacy and Safety of GT20029 Solution in the Treatment of Androgenetic Alopecia (AGA) in Chinese Adult Males

Topical Crisaborole in Patients with Alopecia Areata

Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic Alopecia

A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia.

Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia

A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia

Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata

To Evaluate Safety and Efficacy of KX-826 in Chinese Female Subjects With Androgenetic Alopecia

A Phase 2 Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA)

Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men

To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia

Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia

Phase II Study Evaluating the Efficacy and Safety of KX-826

Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata

Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata

Study to Evaluate the Safety and Efficacy ofJaktinib Hydrochloride Tablets in Severe Alopecia Areata

Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia Areata

Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata

Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)

Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata

Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata

A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001

Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia

The Effect of Platelet-rich Plasma in Subjects With Androgenetic Alopecia

A Phase II Study in Patients With Alopecia Areata

A Study of JNJ-64304500 in Participants With Alopecia Areata

A Study of Secukinumab for the Treatment of Alopecia Areata

A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution

To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin

ENERGI-F701 for Female Hair Loss Treatment

ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)

ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis

Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)

A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata

Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata

Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women

A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing

A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata

Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata

Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)

Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis

A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males

Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants

Adipose Tissue Derived Stem Cell Based Hair Restoration Therapy for Androgenetic Alopecia

Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth

A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo

A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.

HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata

A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)

Retinol Binding Protein 4 Protein in Alopecia Areata Treated With Barcitinib

Efficacy and Safety Of AGE ZERO™ EXOSOMES To Treat Men and Women With Androgenetic Alopecia

Study to Evaluate Safety & Usability of a New Formulation for Male Androgenetic Alopecia

Evaluation of the Safety, Tolerability and Pharmacokinetics of AH-001 Following Topical Single and Multiple Ascending Dose Administration

Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia

To Evaluate the Safety, Tolerability and PK of GT20029 Gel and Solution in Healthy Subjects

A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age

To Evaluate the Safety, Tolerability and Efficacy in Male and Female with AGA Treated with HMI-115 Over a 24-week Treatment Period

A First in Human Single and Multiple Ascending Dose and Open Label Food Effect Study of OR-101 in Healthy Subjects

The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A

Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029

Comparative Efficacy of Tacrolimus and Clobetasol Propionate in Alopecia Areata

A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)

A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)

A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843

the Safety, Tolerability and PK of KX-826 in Healthy Males With Alopecia Following Topical Multiple Dose Ascending

Safety, Tolerability and Pharmacokinetics of KX826 in Healthy Male Subjects With Androgenetic Alopecia Following Topical Single Ascending Dose Administration

Safety and Efficacy of HST 001 in Male Pattern Hair Loss

To Evaluate the Pharmacokinetics and Safety of AD-208

Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia

Photosensitization Study in Androgenetic Alopecia

Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)

Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic Alopecia

Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA)

Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study

A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)

Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

Effect of Platelet-Rich Plasma Versus Placebo in the Treatment of Central Centrifugal Cicatricial Alopecia

Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata

Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss

Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata

N-Acetyl-Cysteine for Treatment of AGA in Men

Hydraderm for Androgenic Alopecia

Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia Areata

Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi.

Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia (CCCA)

Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata

Pain Outcomes Following Intralesional Corticosteroid Injections

Comparison of Topical Minoxidil 5% in Ethanol Plus Propylene Glycol Versus Minoxidil 5% in Ethanol Alone in Treatment of Women With Female Pattern Hair Loss

Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata

The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia